Nov. 6 at 9:18 PM
$MYGN For the 1–2 year sleeve
Fundamentals from the quarter didn’t change: ~70% GM, EBITDA positive, Q3 positive FCF, guide reiterated. That’s why nibbling down here (small size) is reasonable if you can tolerate more chop; just don’t size it like a certainty while price is below
$6.40.
One-liner (if you want to post it)
$MYGN closed
$6.33—broke the
$6.40–6.60 shelf. Save = quick reclaim
$6.40–6.50; otherwise likely tests
$6.05–6.15 (then
$5.6–5.75 if weak). Bigger picture intact, but this part’s about levels. 📉➡️📈
